1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone has been researched along with mupirocin in 1 studies
Studies (1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone) | Trials (1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone) | Recent Studies (post-2010) (1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone) | Studies (mupirocin) | Trials (mupirocin) | Recent Studies (post-2010) (mupirocin) |
---|---|---|---|---|---|
7,666 | 0 | 1,658 | 1,401 | 214 | 567 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arp, J; Bardl, B; Brakhage, AA; Brock, DA; García-Altares, M; Götze, S; Klapper, M; Mattern, DJ; Mukherji, R; Peschel, G; Queller, DC; Stallforth, P; Strassmann, JE; Willing, K | 1 |
1 other study(ies) available for 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone and mupirocin
Article | Year |
---|---|
Synergistic activity of cosecreted natural products from amoebae-associated bacteria.
Topics: 4-Butyrolactone; Anti-Bacterial Agents; Bacterial Proteins; Biological Products; Dictyostelium; Drug Synergism; Genome, Bacterial; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Pseudomonas; Quorum Sensing; Staphylococcal Infections | 2018 |